Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Reboxetine: Pipeline™ Selector' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Reboxetine Pipeline Developer |
Ongoing | £3360 | 100 % |
|
Reboxetine: Core Country Coverage Pipeline Selector |
Ongoing | £260 | 96 % |
|
Reboxetine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 | 96 % |
|
Pfizer Prospects to 2010 Pipeline, Products,Performance,Potential |
September 2007 | £595 | 35 % |
|
Stakeholder Opinions: Fibromyalgia Potentially lucrative market soon to become reality |
May 2007 | £2005 | 33.25 % |
|
Pipeline Insight: Neuropathic Pain Emerging Drugs Fail To Capitalize In Lucrative Market |
September 2007 | £740 | 32.55 % |
|
Stakeholder Insight: Major Depressive Disorder Duloxetine - Fulfilling An Unmet Need? |
March 2006 | £8695 | 23.1 % |
